Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues
Open Access
- 15 March 1992
- journal article
- Published by Elsevier BV in Thrombosis Research
- Vol. 65 (6), 709-719
- https://doi.org/10.1016/0049-3848(92)90110-v
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: Possible roles in tumor progression and metastasisThrombosis Research, 1991
- The concentration of tissue plasminogen activator and urokinase in plasma and tissues of patients with ovarian and uterine tumorsThrombosis Research, 1990
- Comparative study of plasminogen activator antigens in colonic carcinomas and adenomasInternational Journal of Cancer, 1988
- The urokinase type of plasminogen activator in cancer of digestive tractsThrombosis Research, 1988
- The placental type plasminogen activator inhibitor, PAI 2Fibrinolysis, 1987
- Tissue plasminogen activators in breast cancerThrombosis Research, 1987
- Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.The Journal of Experimental Medicine, 1987
- Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate.The Journal of cell biology, 1986
- Plasminogen Activator Released as Inactive Proenzyme from Murine Cells Transformed by Sarcoma VirusJBIC Journal of Biological Inorganic Chemistry, 1982
- Urokinase Inhibitor in Human PlacentaNature, 1968